Fig. 3. Vaccinia virions do not co-distribute with disrupted Golgi markers. Golgi and vaccinia localization in control (A–C and J–L), nocodazole- (D–F and M–O) and brefeldin A- (G–I and P–R) treated cells. Vaccinia virus particles are visualized with the anti-A27L antibody, while the cis-Golgi and trans-Golgi network are labelled with the anti-gp27 and anti-TGN-46 antibodies, respectively. Scale bar = 10 µm.